15 November 2017
At the meeting of 11 October 2017 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
substance use disorder | 59/2017 | 60/2017 |
osteoarthritis | 61/2017 | 62/2017 |
immune thrombocytopaenia | 63/2017 | 64/2017 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined New Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
ulnar neuropathy at the elbow | 65/2017 | 66/2017 |
The above SOPs take effect from 4 December 2017.
Summary of Changes
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
chilblains | Intention to remove one or more factors | 7 February 2018 |
Completed Investigations
The above determinations conclude the previously advertised investigations into:
New Investigations
Decided to advertise the following investigations:
- cluster headache
- Alzheimer-type dementia
- dislocation
- reactive arthritis
- non-Hodgkin's lymphoma
- gout
- joint instability
- iliotibial band syndrome
- methaemoglobinaemia
- sinus barotrauma
- internal derangement of the knee
- acute articular cartilage tear
- acute meniscal tear of the knee
- Dupuytren's disease
- blepharitis
- renal stone disease
- subarachnoid haemorrhage
- pilonidal sinus
- anal fissure
- chronic pruritus ani
- heel bursitis
- chondromalacia patella
- rapidly progressive crescentic glomerulonephritis
- dental malocclusion
- lumbar spondylosis (focussed review - carrying loads, and lifting loads)
- thoracic spondylosis (focussed review - carrying loads, and lifting loads)
- temporomandibular joint dysfunction
- mesenteric panniculitis
The above investigation notices appear in the Government Notices Gazette of 14 November 2017.